Anika Therapeutics Inc (STU:AKP)
€ 18.6 +0.40 (+2.2%) Market Cap: 249.47 Mil Enterprise Value: 238.06 Mil PE Ratio: 0 PB Ratio: 2.10 GF Score: 66/100

Anika Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 18, 2026 / 12:30PM GMT
Release Date Price: €12.4 (+0.81%)
Operator

Good morning, everyone, and welcome to Anika Therapeutics, Inc. 2026 Annual Meeting of Stockholders. Our host for today is Steve Griffin, Anika's President and Chief Executive Officer.

(Operator Instructions)

I will now turn the call over to you, Mr. Griffin, to begin the meeting.

Stephen Griffin
Anika Therapeutics Inc - President, Chief Executive Officer, Director

Good morning, everyone. I'm Steve Griffin, President and Chief Executive Officer of Anika Therapeutics. It's my privilege to welcome you to the Anika Therapeutics 2026 Annual Meeting of Stockholders.

We have stockholders participating via the web portal and the 800 number that we have provided, and have provided the broader public with listen-only access.

Today, I will preside as Chair of this meeting and Ian McLeod, our Senior Vice President, Chief Accounting Officer, and Treasurer, will act as Secretary for the meeting. 8:30 Eastern Time on June 18, and this meeting is officially called to order.

This meeting is being held in accordance with Anika's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot